IL2 and myelodysplastic syndrome: transfused IL-2-activated haploidentical NK cells after cyclophosphamide and fludarabine conditioning and total lymphoid irradiation in relapsed/refractory myelodysplastic syndrome (MDS) and AML patients, and did not use subcutaneous IL-2 post-infusion (94).